Are Marijuana Stocks Poised for a Blow-Out Surge?

	The Floodgates Could Be About to Open Zacks Member, Marijuana has exploded into a multi-billion-dollar industry. In only 10 years, the legislative trend has brought medical marijuana to 37 states, including the District of Columbia, and recreational marijuana to 21 states, including D.C. The most recent victories in Maryland and Missouri together could generate nearly $2 billion in sales within the next few years. U.S. marijuana sales are expected to reach $53 billion by 2026, and global sales are projected to soar to well over $130 billion by 2030. What an immense opportunity for investors! Especially for those who get in now. Another reason to be excited is that marijuana stocks are still trading at huge discounts. But this may not be for long. Some Congressional lawmakers recently held a hearing where both parties spoke in favor of sweeping Federal-level cannabis legalization efforts, which makes sense given mounting public support. A total of 68% of U.S. adults are now in favor of legal marijuana. Today, we're at an historical tipping point and Zacks Marijuana Innovators portfolio is prepared to take full advantage. Keep in mind that few growers, pharmaceuticals, financial firms and suppliers are able to offer higher profit potential. Our approach to finding these gems is diligent and vigilant, but also aggressive. We recently closed gains of +39.7% and even +147.0%.¹ I invite you to look inside the portfolio now and catch its live trades. Your total cost for 30-day access is only $1. You are also invited to download our Special Report, Midterm Election Profits: 5 Stocks Set to Soar, which reveals five stocks that have strong earnings outlooks and are likely to benefit from billions in government spending. Our election reports have recommended some impressive gains. Previous versions of this report have pointed readers to stocks that have climbed as much as +71%, +83% and +185% in the months after the election.¹ Important Reminder: We can't allow too many investors to jump on our selected marijuana stocks. The deadline for entry is midnight Sunday, December 4. ▶ See Stocks Now All the best, Ben Rains Editor of Marijuana Innovators
	¹ The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". https://www.zacks.com/terms_of_service Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through September 12, 2022. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance_disclosure for information about the performance numbers displayed above. Zacks Emails If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606